⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

August 1, 2025

Table 1 from Glycemic Control and Prostate Cancer Mortality Risk in Veterans with Type 2 Diabetes Mellitus

Kinfe G. Bishu Andrew D. Schreiner Nicholas Shungu Vanessa A. Díaz Macelyn Batten Mulugeta Gebregziabher

View Full Paper

Ask AI

Bookmark

Share

Key Points

Glycemic control significantly influences prostate cancer mortality risk in veterans with type 2 diabetes.
Clinical characteristics were analyzed among male veterans to understand the cohort better.
Findings include demographic data that shed light on factors affecting health outcomes.
These insights could help improve targeted healthcare strategies for veterans with diabetes.

Implication

Analysis reveals the impact of glycemic control on prostate cancer mortality risk in veterans with diabetes, highlighting clinical characteristics.

Abstract

Demographic and clinical characteristics at baseline among male veterans with type 2 diabetes in the cohort

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Bishu et al. (2025) studied this question.

synapsesocial.com/papers/689a0c72e6551bb0af8d032e https://doi.org/10.1158/2767-9764.29757227

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Table 3 from Glycemic Control and Prostate Cancer Mortality Risk in Veterans with Type 2 Diabetes Mellitus2025
2Table 2 from Glycemic Control and Prostate Cancer Mortality Risk in Veterans with Type 2 Diabetes Mellitus2025
3Data from Glycemic Control and Prostate Cancer Mortality Risk in Veterans with Type 2 Diabetes Mellitus2025
4Abstract PR013: Glycemic control and risk of prostate cancer morality in Veterans with diabetes2024
5Abstract A062: Glycemic control and risk of total and advanced prostate cancer in Veterans with diabetes: analysis of disparities by race/ethnicity2024